Please login to the form below

Not currently logged in
Email:
Password:

Former Langland exec joins DJM Unlimited

Michael Le Brocq becomes the firm’s new director

Michael Le Brocq DJMDJM Unlimited has appointed Michael Le Brocq as its new board director.

Le Brocq has 20 years' experience in healthcare communications gained client-side, in start-ups and within agencies.

Most recently he led the ethical business unit at Langland, with responsibility for all of the agency's pharmaceutical clients; prior to that he was head of strategy at ICC Lowe.

Following a succession of new account wins, DJM said his new role will be to drive the continued growth of DJM Unlimited within the health and wellness category, providing strategic and business development support to the planning and account teams in London and New York.

He will work alongside Dominic Marchant, MD and founder of DJM Unlimited.

Le Brocq said: “I'm thrilled to be joining Dominic and the team at DJM Unlimited, it's a rare opportunity to be part of a forward-thinking agency enjoying explosive growth by breaking the mould of what digital means in healthcare.”

Meanwhile, former Director Mark Hartley, has become head of  DJM Unlimited's sister agency Plastic Unlimited, a digital experiential and motion graphics creative agency focusing more on the consumer/retail client base.

1st July 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics